Skip to main content

Table 3 Analysis of prognostic factors associated with survival in patients resected for LMGC

From: Surgical treatment of liver metastases of gastric cancer: state of the art

Author year n Period T N G H DIAM metastases TIMING MARGIN MST Long-term survivors Recurrence Follow-up (months)
1994 [30] 21   + + - - NA NA NA 18 19% (4) NA  
1997 [43] 21   - - - + NA - NA NA 24% (5) 76.1% NA
2001 [23] 17 1990-1997 - + + - NA + + 16 0 76% Na
2001 [9] 40 1975-1999 - - - - - + - 12 15% (6) 75% 88
2001 [45] 10 1979-1999 - - - - + + NA 16 10% (1) 80% 10-240
2002 [33] 15 1980-1999 - - - + - + - 8.8 0 90% na
2002 [31] 10 1981-1998 - - - - - - NA 25 20% (2) 80% 1-68
2002 [28] 19 1986-1999 - - + + - + NA 21 14% (3) 74% Na
2003 [25] 22 1985-2001 * - - + + - NA 24 20% (5) 68% Na
2003 [41] 36 1979-2001 - Ly - + - - - NA 11% (4) 83.3% NA
2005 [29] 11 1988-1996 NA - - NA - - - 19 18% (2) 80 Na
2007 [34] 42 1985-2005 + - - + - - - 34 20% (8) 67% 1-86
2007 [44] 37 1990-2005 + - - + + - - 31 6 % (2) 81 % Na
2008 [24] 24 1988-2002 - - - - - - + 19 8% (2) 65% 1-67
2008 [40] 18 1989-2004 + - - - - - - NA 17% (3) Na 2-200
2008 [37] 22 1995-2005          15% (3) 63.6% 1-106
2009 [47] 17 1991-2005 - - - - - - + 18 25% (4) 70.5% 1-117
Choi 2010 14 1986-2007 - - - - - - - NA 8% (1) 63% Na
Tsujmoto 2010 17 1980-2007 + Ly NA - - - NA 34 30% (5) 70% Na
Our data              
2012 21 1998-2007          14.2% (3) 66% 6-90
  1. H1, Metastases limited to one lobe; H2, few scattered metastases in both liver lobes; H3, numerous scattered metastases in both lobes; M, Metachronous; mets, metastases; Na, Not available; S, Synchronous; STG, Subtotal gastrectomy; TG, Total gastrectomy; Number of patients resected on a total of patients with LMGC.